Precision Biosciences Inc
DTIL· Nasdaq
DTILPrecision Biosciences Inc
Filed Nov 10, 2020 · 10-Q · 41 days after period end · 0001564590-20-052737
| Metric | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|
| Revenue | $7.36M | $4.87M | $2.54M |
| Net Income | -$26.02M | -$20.74M | -$9.76M |
| EPS Diluted | -$0.50 | -$0.41 | -$0.62 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 10, 2020 · 41 d after period end
